Analysts at KeyCorp initiated coverage on shares of Chemed Corp. (NYSE:CHE) in a report issued on Monday. The brokerage set a “sector weight” rating on the stock.

Several other equities research analysts have also recently commented on the company. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $208.00 price target on shares of Chemed Corp. in a report on Wednesday, July 5th. BidaskClub cut Chemed Corp. from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 22nd. Zacks Investment Research cut Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, May 2nd. Oppenheimer Holdings, Inc. raised their price target on Chemed Corp. from $200.00 to $220.00 and gave the stock an “outperform” rating in a research report on Thursday, July 27th. Finally, TheStreet lowered Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $214.00.

Shares of Chemed Corp. (CHE) traded up 0.50% during midday trading on Monday, reaching $192.63. The company had a trading volume of 2,209 shares. Chemed Corp. has a 12-month low of $131.16 and a 12-month high of $216.01. The company has a 50 day moving average of $197.59 and a 200 day moving average of $193.57. The firm has a market capitalization of $3.08 billion, a price-to-earnings ratio of 47.79 and a beta of 1.14.

Chemed Corp. (NYSE:CHE) last issued its earnings results on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.26. Chemed Corp. had a return on equity of 26.18% and a net margin of 4.16%. The firm had revenue of $415.06 million for the quarter, compared to the consensus estimate of $407.56 million. During the same quarter in the prior year, the business earned $1.80 earnings per share. The company’s revenue was up 6.3% compared to the same quarter last year. Analysts anticipate that Chemed Corp. will post $8.20 EPS for the current year.

TRADEMARK VIOLATION WARNING: “KeyCorp Initiates Coverage on Chemed Corp. (CHE)” was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/08/28/keycorp-initiates-coverage-on-chemed-corp-che.html.

In other news, Director George J. Walsh III bought 1,000 shares of the business’s stock in a transaction dated Monday, June 26th. The shares were acquired at an average price of $204.56 per share, for a total transaction of $204,560.00. Following the completion of the transaction, the director now owns 7,908 shares of the company’s stock, valued at $1,617,660.48. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Kevin J. Mcnamara sold 15,000 shares of Chemed Corp. stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $201.16, for a total value of $3,017,400.00. Following the sale, the insider now owns 173,801 shares in the company, valued at approximately $34,961,809.16. The disclosure for this sale can be found here. 5.32% of the stock is currently owned by insiders.

Several hedge funds have recently bought and sold shares of the company. BNP Paribas Arbitrage SA boosted its position in shares of Chemed Corp. by 1.0% in the first quarter. BNP Paribas Arbitrage SA now owns 3,891 shares of the company’s stock valued at $711,000 after buying an additional 39 shares during the period. Municipal Employees Retirement System of Michigan boosted its position in shares of Chemed Corp. by 1.1% in the first quarter. Municipal Employees Retirement System of Michigan now owns 3,700 shares of the company’s stock valued at $676,000 after buying an additional 40 shares during the period. Kalos Management Inc. boosted its position in shares of Chemed Corp. by 0.7% in the second quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock valued at $1,333,000 after buying an additional 45 shares during the period. Capstone Asset Management Co. boosted its position in shares of Chemed Corp. by 2.7% in the second quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock valued at $380,000 after buying an additional 49 shares during the period. Finally, State of Alaska Department of Revenue boosted its position in shares of Chemed Corp. by 2.8% in the first quarter. State of Alaska Department of Revenue now owns 1,810 shares of the company’s stock valued at $330,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 96.96% of the company’s stock.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.